![]() Orexo Orexo, a specialty pharmaceutical company, engages in the development and commercialization of drugs. | ||
Founding Date | Founding Date 1995 | Founding Date 1997 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Uppsala, SE HQ Uppsala, SE Morristown, US | Locations Lund, SE HQ |
Employees | Employees 110 | Employees 118 |
Valuation ($) | Valuation ($) 36.3 m | Valuation ($) 285.9 m |
Financial | ||
Revenue (est.) | Revenue (est.) kr26m (FY, 2025) | Revenue (est.) kr226.5m (FY, 2025) |
Cost of goods | Cost of goods kr14.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit kr18m (FY, 2025) | Gross profit kr226.6m (FY, 2025) |
Net income | Net income (kr403.3m) (FY, 2025) | Net income (kr332.9m) (FY, 2025) |

BioInvent focuses on the discovery and development of antibody-based drugs against cancer.
View company